Tislelizumab-Lenvatinib Shows Promise for High-Risk Liver Cancer
In a groundbreaking advance that could redefine the therapeutic landscape for liver cancer, a new single-arm phase II clinical trial ...
Tag: multi-targeted tyrosine kinase inhibitors
Cabozantinib Alters Hormone Levels in Kidney Cancer Patients
Recent advances in cancer therapy have brought about significant interest in the role of hormonal regulation in malignancies. A remarkable ...
Radiomics Predicts Lenvatinib Success in Liver Cancer
In the realm of oncology, the quest for precision medicine has led to intriguing advancements that hold promise for cancer ...
RALOX-HAIC Plus Lenvatinib Boosts Elderly Liver Cancer Survival
A groundbreaking study published in BMC Cancer unveils a promising therapeutic advancement for elderly patients suffering from unresectable hepatocellular carcinoma ...
Rechallenging Immunotherapy Plus Anlotinib in Lung Cancer
In the relentless battle against advanced non-small cell lung cancer (NSCLC), a groundbreaking retrospective study has shed light on the ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!